These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19383808)

  • 41. Chemokines and cancer.
    Zlotnik A
    Int J Cancer; 2006 Nov; 119(9):2026-9. PubMed ID: 16671092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of CXCR4-mediated breast cancer metastasis: a potential role for heparinoids?
    Harvey JR; Mellor P; Eldaly H; Lennard TW; Kirby JA; Ali S
    Clin Cancer Res; 2007 Mar; 13(5):1562-70. PubMed ID: 17332302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer.
    Li JY; Ou ZL; Yu SJ; Gu XL; Yang C; Chen AX; Di GH; Shen ZZ; Shao ZM
    Breast Cancer Res Treat; 2012 Feb; 131(3):837-48. PubMed ID: 21479551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential chemokine, chemokine receptor, cytokine and cytokine receptor expression in pulmonary adenocarcinoma: diffuse down-regulation is associated with immune evasion and brain metastasis.
    Ohshima K; Hamasaki M; Makimoto Y; Yoneda S; Fujii A; Takamatsu Y; Nakashima M; Watanabe T; Kawahara K; Kikuchi M; Shirakusa T
    Int J Oncol; 2003 Oct; 23(4):965-73. PubMed ID: 12963975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells.
    Holland JD; Kochetkova M; Akekawatchai C; Dottore M; Lopez A; McColl SR
    Cancer Res; 2006 Apr; 66(8):4117-24. PubMed ID: 16618732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Organ selectivity in metastasis: regulation by chemokines and their receptors.
    Ben-Baruch A
    Clin Exp Metastasis; 2008; 25(4):345-56. PubMed ID: 17891505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CCR9 in cancer: oncogenic role and therapeutic targeting.
    Tu Z; Xiao R; Xiong J; Tembo KM; Deng X; Xiong M; Liu P; Wang M; Zhang Q
    J Hematol Oncol; 2016 Feb; 9():10. PubMed ID: 26879872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines.
    Locati M; Torre YM; Galliera E; Bonecchi R; Bodduluri H; Vago G; Vecchi A; Mantovani A
    Cytokine Growth Factor Rev; 2005 Dec; 16(6):679-86. PubMed ID: 15996892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression of chemokine receptors by cancer cells].
    André F; Soria JC; Assi H; Delaloge S; Spielmann M
    Bull Cancer; 2004 Dec; 91 Suppl 4():S254-6. PubMed ID: 15899617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An attractive force in metastasis.
    Liotta LA
    Nature; 2001 Mar; 410(6824):24-5. PubMed ID: 11242022
    [No Abstract]   [Full Text] [Related]  

  • 51. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.
    Xiao G; Wang X; Wang J; Zu L; Cheng G; Hao M; Sun X; Xue Y; Lu J; Wang J
    Oncotarget; 2015 Jun; 6(16):14165-78. PubMed ID: 25909173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7.
    Li JT; Jia LT; Liu NN; Zhu XS; Liu QQ; Wang XL; Yu F; Liu YL; Yang AG; Gao CF
    Oncotarget; 2015 Oct; 6(31):30818-30. PubMed ID: 26360780
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis.
    Ejaeidi AA; Craft BS; Puneky LV; Lewis RE; Cruse JM
    Exp Mol Pathol; 2015 Aug; 99(1):163-72. PubMed ID: 26079660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemokines in neuroectodermal tumour progression and metastasis.
    Raffaghello L; Cocco C; Corrias MV; Airoldi I; Pistoia V
    Semin Cancer Biol; 2009 Apr; 19(2):97-102. PubMed ID: 19013246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines.
    Opdenakker G; Van Damme J
    Int J Dev Biol; 2004; 48(5-6):519-27. PubMed ID: 15349826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CRAM-A indicates IFN-γ-associated inflammatory response in breast cancer.
    Sarmadi P; Tunali G; Esendagli-Yilmaz G; Yilmaz KB; Esendagli G
    Mol Immunol; 2015 Dec; 68(2 Pt C):692-8. PubMed ID: 26563945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.
    Purvanov V; Matti C; Samson GPB; Kindinger I; Legler DF
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. GPR116, an adhesion G-protein-coupled receptor, promotes breast cancer metastasis via the Gαq-p63RhoGEF-Rho GTPase pathway.
    Tang X; Jin R; Qu G; Wang X; Li Z; Yuan Z; Zhao C; Siwko S; Shi T; Wang P; Xiao J; Liu M; Luo J
    Cancer Res; 2013 Oct; 73(20):6206-18. PubMed ID: 24008316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma.
    Shi JY; Yang LX; Wang ZC; Wang LY; Zhou J; Wang XY; Shi GM; Ding ZB; Ke AW; Dai Z; Qiu SJ; Tang QQ; Gao Q; Fan J
    J Pathol; 2015 Mar; 235(4):546-58. PubMed ID: 25255875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of CXC chemokine ligand 4/CXC chemokine receptor 3-B in breast cancer progression.
    Saahene RO; Wang J; Wang ML; Agbo E; Song H
    Biotech Histochem; 2019 Jan; 94(1):53-59. PubMed ID: 30264586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.